Genentech To Collaborate With ABC2 For Brain Cancer Research
Biotech Company and Non-Profit Foundation Join Forces
Under the collaboration, ABC2 will share development expenses with Genentech and provide access to its resources, including relationships with leading researchers and clinicians. Genentech will contribute its world-renowned experience in designing and developing pioneering therapeutics to the venture. Genentech would commercialize any resulting products and ABC2 would receive a royalty on product sales.
"Today's announcement represents a revolutionary new model for us to work with the biotechnology and pharmaceutical industries to advance the search for a cure for this devastating disease," said Steve Case, chairman of AOL/Time Warner, and chairman of ABC2. "This is just the first of a series of collaborations that ABC2 will announce which we believe will significantly improve the prospects for the treatment of brain cancer."
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.